Alpha Centric Advisors LLC Abb Vie Inc. Transaction History

Alpha Centric Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $2,024 - $2,331	-14 Reduced 0.83%	1,679 $267,000
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $49,514 - $59,381	358 Added 26.82%	1,693 $274,000
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $179,170 - $205,496	1,335 New	1,335 $179,000
Q3 2021 Mar 09, 2022	SELL	$106.4 - $120.78 $45,220 - $51,331	-425 Closed	0 $0
Q2 2020 Mar 11, 2022	BUY	$73.37 - $98.18 $31,182 - $41,726	425 New	425 $42,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.